Surgery

Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate at 3 to 6 months, though patient selection is crucial. Some required multiple treatments, but overall outcomes are promising.

Custom-designed, lens-based surgery is a less interventional surgical option.

A Norwegian study demonstrates that transplant rates continue to drop over time

Marketed as Triesence, it is a preservative free synthetic corticosteroid that is approved by the FDA for visualization during vitrectomy and for the treatment of ocular inflammatory conditions that are unresponsive to topical corticosteroids.

Clobetasol is FDA-approved for the treatment of post-operative inflammation and pain following ocular surgery.

In a study, a team of Chinese researchers looked at the mechanisms behind the development of EI and explored effective treatment options.

The Gni instrument technology represents a significant innovation in ophthalmic surgery, particularly in cataract procedures, according to Gulani.

According to the company, the center, which officially opens on Thursday, September 26, will serve as a hub for hands-on training and education in lens-based vision correction.

The study, funded by the National Institutes of Health, supports no change to surgical technique for trichiasis management.

The new standard: Stabilizing keratoconus and improving vision.

Unlocking the potential of donor scleral tissue: Innovations and future applications.

Researchers from NYU Langone published a study reporting on the eye's functioning, without sight but offering hope for the future.

APP13007, according to the company, is the first product developed using Formosa’s proprietary APNT nanoparticle formulation platform.

In a 10-year retrospective study, a team of researchers in China found the top 2 categories for cancellations were medical factors and patient-related factors.

The option is a definitive step forward in the field of vitreoretinal surgery

Eastern Kentucky University student Madison Carlisle experienced rapid vision loss until the team at UK HealthCare was able to unravel the source of her issues.

Technologies continue to push retina surgical suites into the future

The Australian Society of Ophthalmologists hosted its inaugural Eye Surgery Showcase, where participants learned how ophthalmologists and the medical technology industry are working together to save the sight of Australians.

The device features real-time feedback and other features, allowing residents to hone their skills and expand options for practicing one of the most needed procedures in the country.

The agreement with give Apotex exclusive rights in Canada for the commercialization of APP13007.

A team of 14 eyecare professionals made the recent trip including faculty from the Loyola Medicine Department of Ophthalmology and faculty and residents from Cook County Health, Northwestern Medicine, Wills Eye Hospital in Philadelphia, the University of Toledo College of Medicine and Champlain Ophthalmology in Bethesda, Maryland.

iStent implantations increased sharply, whereas trabeculectomies saw a decline.

Lens feathering resulting from intraocular gas can interfere with the visualization needed to perform posterior segment surgery

Funding for the device was thanks to companies like Nike and the Oregon ToughTech Breakthrough Fund.

The purpose of the study was to determine if experience affects the surgeons’ dexterity response to pharmacologic and behavioral interventions.

From amniotic membrane grafting to neurotization.

Plasma emission for blepharitis, meibomian gland dysfunction, and dry eye disease.

According to the company, its combined vitreoretinal-cataract system and standalone cataract system are cleared for use in the United States.

The electromagnetic driving systems are proposed for the flexible 5-DOF magnetic manipulation of a micro-robot within the posterior eye, enabling precise targeted drug delivery.